- Home
- CGON vs IAG Comparison
CGON vs IAG Comparison
Compare CGON & IAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- IAG
- Stock Information
- Founded
- CGON 2010
- IAG 1990
- Country
- CGON United States
- IAG Canada
- Employees
- CGON 61
- IAG 3700
- Industry
- CGON
- IAG Precious Metals
- Sector
- CGON
- IAG Basic Materials
- Exchange
- CGON NYSE
- IAG Nasdaq
- Market Cap
- CGON 2.2B
- IAG 2.8B
- IPO Year
- CGON 2024
- IAG 1996
- Fundamental
- Price
- CGON $32.84
- IAG $4.95
- Analyst Decision
- CGON Strong Buy
- IAG Buy
- Analyst Count
- CGON 8
- IAG 6
- Target Price
- CGON $63.88
- IAG $7.40
- AVG Volume (30 Days)
- CGON 396.6K
- IAG 8.3M
- Earning Date
- CGON 11-12-2024
- IAG 11-07-2024
- Dividend Yield
- CGON N/A
- IAG N/A
- EPS Growth
- CGON N/A
- IAG 420.20
- EPS
- CGON N/A
- IAG 1.38
- Revenue
- CGON $684,000.00
- IAG $1,460,700,000.00
- Revenue This Year
- CGON $411.76
- IAG $68.68
- Revenue Next Year
- CGON $405.27
- IAG $38.44
- P/E Ratio
- CGON N/A
- IAG $3.90
- Revenue Growth
- CGON 258.12
- IAG 62.90
- 52 Week Low
- CGON $25.77
- IAG $2.11
- 52 Week High
- CGON $50.23
- IAG $6.37
- Technical
- Relative Strength Index (RSI)
- CGON 41.08
- IAG 41.03
- Support Level
- CGON $35.12
- IAG $4.89
- Resistance Level
- CGON $40.47
- IAG $5.88
- Average True Range (ATR)
- CGON 1.69
- IAG 0.24
- MACD
- CGON -0.28
- IAG -0.08
- Stochastic Oscillator
- CGON 4.57
- IAG 5.56
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About IAG Iamgold Corporation
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Burkina Faso - Essakane mine, Canada - Doyon division, including Westwood mine. The company's s non-gold mine segments are the Cote Gold project, Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Burkina Faso segment.